A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects

Key Inclusion Criteria: * Males, between 18 and 64 years of age, inclusive * With body weight ≥ 50 kg and body mass index (BMI) between 18 and 32 kg/m2, inclusive * In good health, determined by no clinically significant findings from medical history, 12-lead ECG, and vital signs * Negative test for selected drugs of abuse at Screening and at Check-in * Able to comprehend and willing to sign an Informed Consent Form (ICF) prior to any study procedure * A typical minimum of 1 to 2 bowel movements per day Key Exclusion Criteria: * History of sensitivity to any of the study medications or components thereof or a history of medication or other allergy that, in the opinion of the Investigator, contraindicates their participation * Participation in any other investigational study drug trial in which receipt of an investigational study drug occurred within 28 days prior to Check-in * Participation in any other radiolabeled investigational study drug trial within 12 months prior to Check-in * Exposure to significant radiation (eg, serial x-ray or computed tomography scans, barium meal, current employment in a job requiring radiation exposure monitoring) within 12 months prior to Check-in * Has current malignancy, current systemic chemotherapy, or cancer diagnosis within 5 years prior to Screening (excluding squamous or basal cell carcinoma of the skin that has been clinically stable and fully excised in a curative procedure); * Use of any tobacco- or nicotine-containing products within 6 months prior to Screening